Maria Mazurkiewicz‐Bełdzińska

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Elizabeth A. Thiele, Eric D. Marsh, Jacqueline A. French et al. · The Lancet · 2018 · 887 citations

Medicine, Neurology, Pharmacology +9

Randomized phase III study 306

Gregory L. Krauss, José M. Serratosa, Vicente Villanueva et al. · Neurology · 2012 · 429 citations

Medicine, Pharmacology, Pharmacotherapy +15

Adjunctive lacosamide for partial‐onset seizures: Efficacy and safety results from a randomized controlled trial

Péter Halász, Reetta Kälviäinen, Maria Mazurkiewicz‐Bełdzińska et al. · Epilepsia · 2009 · 392 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study

Burt Nabors, Karen Fink, Tom Mikkelsen et al. · Neuro-Oncology · 2015 · 235 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Cannabidiol in patients with Lennox‐Gastaut syndrome: Interim analysis of an open‐label extension study

Elizabeth A. Thiele, Eric D. Marsh, Maria Mazurkiewicz‐Bełdzińska et al. · Epilepsia · 2019 · 140 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13